{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:28:57Z","timestamp":1793042937268,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.radonc.2009.06.006","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T09:28:31Z","timestamp":1246526911000},"page":"472-476","source":"Crossref","is-referenced-by-count":45,"title":["Effect of selective inhibitors of inflammation on oral mucositis: Preclinical studies"],"prefix":"10.1016","volume":"92","author":[{"given":"Julia","family":"Haagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Krohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"R\u00f6llig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Wolfram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2009.06.006_bib1","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/cncr.23898","article-title":"Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life","volume":"113","author":"Elting","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.06.006_bib2","first-page":"13","article-title":"Clinical and economic consequences of mucositis induced by chemotherapy and\/or radiation therapy","volume":"5","author":"Murphy","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1016\/j.radonc.2009.06.006_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","article-title":"Radiation treatment breaks and ulcerative mucositis in head and neck cancer","volume":"13","author":"Russo","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2009.06.006_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2007.03.010","article-title":"Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation","volume":"68","author":"Bese","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2009.06.006_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","article-title":"Consequential late effects in normal tissues","volume":"61","author":"D\u00f6rr","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.06.006_bib6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2009.06.006_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","article-title":"Updated clinical practice guidelines for the prevention and treatment of mucositis","volume":"109","author":"Keefe","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.06.006_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","article-title":"Management of oral mucositis in patients who have cancer","volume":"52","author":"Lalla","year":"2008","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.radonc.2009.06.006_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semradonc.2008.09.006","article-title":"Strategies for managing radiation-induced mucositis in head and neck cancer","volume":"19","author":"Rosenthal","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2009.06.006_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOO.0b013e3280523ad6","article-title":"Mucositis: biology and management","volume":"15","author":"Treister","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2009.06.006_bib11","first-page":"3","article-title":"Pathobiology of oral mucositis: novel insights and opportunities","volume":"5","author":"Sonis","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1016\/j.radonc.2009.06.006_bib12","doi-asserted-by":"crossref","unstructured":"D\u00f6rr W. Pathogenesis of normal tissue side effects. In: Joiner M, Van der Kogel A. (Hrsg.). Basic clinical radiobiology. 4th ed. London: Hodder Arnold; 2009. p. 169\u201390 [Chapter 13].","DOI":"10.1201\/b13224-14"},{"key":"10.1016\/j.radonc.2009.06.006_bib13","first-page":"15","article-title":"COX-1 and COX-2 tissue expression: implications and predictions","volume":"49","author":"Crofford","year":"1997","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.radonc.2009.06.006_bib14","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.2741\/2881","article-title":"Tumor necrosis factor (TNF) biology and cell death","volume":"13","author":"Bertazza","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.radonc.2009.06.006_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.radonc.2009.06.006_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/09553000500196136","article-title":"Reduction of oral mucositis by palifermin (rHuKGF): dose effect of rHuKGF","volume":"81","author":"D\u00f6rr","year":"2005","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2009.06.006_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/09553000500168515","article-title":"Effect of EGFR-inhibition on the radiation response of oral mucosa \u2013 experimental studies in mouse tongue epithelium","volume":"81","author":"Fehrmann","year":"2005","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2009.06.006_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00066-007-1594-4","article-title":"Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa","volume":"183","author":"Gehrisch","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2009.06.006_bib19","doi-asserted-by":"crossref","unstructured":"D\u00f6rr W. Time factors in normal tissues responses to irradiation. In: Joiner M, Van der Kogel A, editors. Basic clinical radiobiology. 4th ed. London: Hodder Arnold; 2009. p. 149\u201357 [Chapter 11].","DOI":"10.1201\/b13224-12"},{"key":"10.1016\/j.radonc.2009.06.006_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/path.2284","article-title":"Macrophage activation by endogenous danger signals","volume":"214","author":"Zhang","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.radonc.2009.06.006_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1269\/jrr.47.9","article-title":"Altered immune cell proportions in the radiodermatitis induced hairless mice-1 (HR-1)","volume":"47","author":"Maeng","year":"2006","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.radonc.2009.06.006_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1601-0825.2006.01254.x","article-title":"Histomorphometry and immunohistochemical features of grade I (WHO) oral radiomucositis","volume":"13","author":"Bonan","year":"2007","journal-title":"Oral Dis"},{"key":"10.1016\/j.radonc.2009.06.006_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH754>3.0.CO;2-P","article-title":"Increase of RM3\/1-positive macrophages in radiation-induced oral mucositis","volume":"193","author":"Handschel","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.radonc.2009.06.006_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ctrv.2007.03.001","article-title":"The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs","volume":"33","author":"Logan","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2009.06.006_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00520-006-0050-9","article-title":"Anti-inflammatory agents in the management of alimentary mucositis","volume":"14","author":"Lalla","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2009.06.006_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03039287","article-title":"Therapeutische Beeinflussung der radiogenen oralen Mukositis","volume":"173","author":"D\u00f6rr","year":"1997","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2009.06.006_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(85)80005-0","article-title":"Prophylactic administration of indomethacin for irradiation esophagitis","volume":"3","author":"Nicolopoulos","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2009.06.006_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000200480","article-title":"Protection by indomethacin against acute radiation esophagitis","volume":"47","author":"Tochner","year":"1990","journal-title":"Digestion"},{"key":"10.1016\/j.radonc.2009.06.006_bib29","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/en.2007-0132","article-title":"Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes","volume":"148","author":"Ara\u00fajo","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.radonc.2009.06.006_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1432-2277.2008.00802.x","article-title":"Inhibition of TNF-alpha reduces transplant arteriosclerosis in a murine aortic transplant model","volume":"22","author":"Wollin","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.radonc.2009.06.006_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7150\/ijms.5.169","article-title":"Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis","volume":"5","author":"Fries","year":"2008","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.radonc.2009.06.006_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","article-title":"Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial","volume":"82","author":"Attal","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2009.06.006_bib33","first-page":"357","article-title":"Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients","volume":"12","author":"Stockschl\u00e4der","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2009.06.006_bib34","first-page":"203","article-title":"Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation","volume":"13","author":"Van der Jagt","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2009.06.006_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bcp.2008.06.015","article-title":"Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB","volume":"76","author":"Funakoshi-Tago","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.radonc.2009.06.006_bib36","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/01.COC.0000074149.95710.40","article-title":"Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor","volume":"26","author":"Liang","year":"2003","journal-title":"Am J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009003181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009003181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T05:23:51Z","timestamp":1589952231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814009003181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0167814009003181"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2009.06.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}